prednimustine has been researched along with Metastase in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckley, S; Murphy, GP; Slack, NH; Wajsman, LZ | 1 |
| Fridrik, M; Hausmaninger, H; Hehenwarter, W; Lehnert, M; Manfreda, D; Michlmayr, G; Samonigg, H; Schiller, L; Sevelda, P; Steger, G | 1 |
| Allegra, JC | 1 |
3 trial(s) available for prednimustine and Metastase
| Article | Year |
|---|---|
Chemotherapy in metastatic, hormone refractory prostatic cancer using chlorambucil in combination with prednisolone versus conjugate, prednimustine (Leo 1031).
Topics: Aged; Antineoplastic Agents; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Male; Middle Aged; Neoplasm Metastasis; Prednimustine; Prednisolone; Prostatic Neoplasms | 1981 |
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Germany, West; Humans; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neoplasm Metastasis; Prednimustine; Randomized Controlled Trials as Topic; Survival Rate; Vindesine | 1989 |
A randomized comparative study of prednimustine and doxorubicin in patients with metastatic breast cancer.
Topics: Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Doxorubicin; Female; Humans; Neoplasm Metastasis; Prednimustine; Random Allocation | 1986 |